Learning Objective

1. Review epidemiology, histology and prognostic features of triple negative breast cancer

2. Describe the key trials for development of current standard of care regimens

3. Articulate toxicities of new treatments and long-term impact on patient quality of life

Session date: 
01/19/2024 - 8:00am to 9:00am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Anshu Hemrajani, MD